Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date

JHOP - December 2020 Vol 10, No 6

Outcomes for Patients Receiving Ibrutinib with or without Antifungal Therapy
JHOP - December 2020 Vol 10, No 6 - Original Research
Read More
The Safety Profile of Mini-Dose Methotrexate for Graft-versus-Host Disease Prophylaxis: Is There a Place for Folinic Acid Rescue?
JHOP - December 2020 Vol 10, No 6 - Original Research
Read More
Evaluation of Inpatient Oral Chemotherapy: An Academic Medical Center Experience
JHOP - December 2020 Vol 10, No 6 - Original Research
Read More
Vaccination Rates in Patients with Hematologic Cancers After Hematopoietic Stem-Cell Transplant: A Single-Center Retrospective Study
JHOP - December 2020 Vol 10, No 6 - Original Research
Read More
Desensitization Permits Continued Trastuzumab and Ado-Trastuzumab Emtansine Therapy After Hypersensitivity Reaction
JHOP - December 2020 Vol 10, No 6 - Case Reports
Read More
HOPA 2020 Abstracts, Part IV
JHOP - December 2020 Vol 10, No 6 - HOPA
These abstracts represent the balance of studies featured during the poster presentation at the 16th Annual Conference of the Hematology/Oncology Pharmacy Association (HOPA) in April 2020 in Tampa, FL. The other abstracts were previously published in the June, August, and October issues of the journal.
Read More
September-December 1, 2020: Recent Cancer Drugs Approved by the FDA
JHOP - December 2020 Vol 10, No 6 - FDA Updates
This section provides a brief overview of new cancer drugs or new indications approved by the FDA between September 1, 2020, and December 1, 2020.
Read More

Results 1 - 7 of 7